Evolocumab effectiveness in the real-world setting: Austrian data from the pan-European observational HEYMANS study.

Autor: Ebenbichler C; Department of Internal Medicine I, Medical University Innsbruck, Anichstraße 35, 6020, Innsbruck, Austria. Christoph.Ebenbichler@i-med.ac.at., Drexel H; Vorarlberg Institute for Vascular Investigation & Treatment (VIVIT) at Feldkirch Academic Teaching Hospital, Feldkirch, Austria., Hanusch U; Center for Clinical Studies, Dr. Hanusch GmbH, Vienna, Austria., Toplak H; Department of Internal Medicine, Medical University Graz, Graz, Austria., Dhalwani NN; Amgen Inc., Thousand Oaks, CA, USA., Bridges I; Amgen Ltd., Uxbridge, UK., Hoelzl R; Amgen GmbH, Vienna, Austria., Hemetsberger M; Hemetsberger medical services, Vienna, Austria., Ray KK; Imperial Centre for Cardiovascular Disease Prevention and Imperial Clinical Trials Unit, Imperial College London, London, UK.

Publikováno v: Wiener klinische Wochenschrift [Wien Klin Wochenschr] 2024 Feb; Vol. 136 (3-4), pp. 77-86. Date of Electronic Publication: 2023 Jul 31.

Characteristics and outcomes of patients with psoriasis treated with apremilast in the real-world in Austria - results the APPRECIATE study.

Autor: Jonak C; Department of Dermatology, Medical University of Vienna, Vienna, Austria., Göttfried I; Dermatology Practice, Vienna, Austria., Perl-Convalexius S; Dermatology Practice, Vienna, Austria., Gruber B; Department of Dermatology and Venerology, Klinikum Wels-Grieskirchen, Wels, Austria., Schütz-Bergmayr M; Department of Dermatology, Kepler University Hospital, Linz, Austria., Vujic I; Faculty of Medicine and Dentistry, Danube Private University, Krems an der Donau, Austria.; Department of Dermatology, Klinik Landstraße, Vienna, Austria., Weger W; Department of Dermatology, Medical University Graz, Graz, Austria., Schicher N; Dermatology Practice, Klagenfurt, Austria., Semlin L; Amgen GmbH, Vienna, Austria., Hemetsberger M; hemetsberger medical services, Vienna, Austria., Cordey M; Amgen Inc, Thousand Oaks, CA, USA., Sator P; Department of Dermatology, Municipal Hospital Hietzing, Wolkersbergenstraße 1, A-1130 Vienna, Austria.

Publikováno v: Therapeutic advances in chronic disease [Ther Adv Chronic Dis] 2023 Feb 07; Vol. 14, pp. 20406223231152785. Date of Electronic Publication: 2023 Feb 07 (Print Publication: 2023).

Epidemiology and economic burden of fragility fractures in Austria.

Autor: Muschitz, C., Hummer, M., Grillari, J., Hlava, A., Birner, A. H., Hemetsberger, M., Dimai, H. P.

Publikováno v: Osteoporosis International; Mar2022, Vol. 33 Issue 3, p637-647, 11p, 1 Chart, 2 Graphs

Sex-Related Differences in Drugs with Anti-Inflammatory Properties.

Autor: Farkouh A; Department of Pharmaceutical Sciences, University of Vienna, 1090 Vienna, Austria., Baumgärtel C; AGES Austrian Medicines and Medical Devices Agency and Austrian Federal Office for Safety in Health Care, 1200 Vienna, Austria., Gottardi R; Vascular Surgery, MediClin Heart Institute Lahr/Baden, 77933 Lahr, Germany., Hemetsberger M; Hemetsberger Medical Services, 1070 Vienna, Austria., Czejka M; Department of Pharmaceutical Sciences, University of Vienna, 1090 Vienna, Austria., Kautzky-Willer A; Gender Medicine Unit, Division of Endocrinology and Metabolism, Department of Internal Medicine III, Medical University of Vienna, 1090 Vienna, Austria.

Publikováno v: Journal of clinical medicine [J Clin Med] 2021 Apr 01; Vol. 10 (7). Date of Electronic Publication: 2021 Apr 01.

Advancements in Therapeutic Approaches for Degenerative Tendinopathy: Evaluating Efficacy and Challenges.

Autor: Morya, Vivek Kumar^1,2 (AUTHOR) moryavivek@hallym.ac.kr, Shahid, Hamzah^1,2 (AUTHOR) langjun1994@gmail.com, Lang, Jun^1,2 (AUTHOR), Kwak, Mi Kyung^1,2 (AUTHOR), Park, Sin-Hye³ (AUTHOR), Noh, Kyu-Cheol^2,4 (AUTHOR) happyshoulder@hallym.ac.kr

Publikováno v: International Journal of Molecular Sciences. Nov2024, Vol. 25 Issue 21, p11846. 36p.